Articles amb requisits d'accés públic - Sanjay MathewMés informació
No estan disponibles en cap lloc: 19
Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder
RB Price, DC Shungu, X Mao, P Nestadt, C Kelly, KA Collins, ...
Biological psychiatry 65 (9), 792-800, 2009
Requisits: US National Institutes of Health
Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics
SJ Mathew, RB Price, DS Charney
American Journal of Medical Genetics Part C: Seminars in Medical Genetics …, 2008
Requisits: US National Institutes of Health
Impact of childhood emotional abuse on neocortical neurometabolites and complex emotional processing in patients with generalized anxiety disorder
E Raparia, JD Coplan, CG Abdallah, PR Hof, X Mao, SJ Mathew, ...
Journal of affective disorders 190, 414-423, 2016
Requisits: US National Institutes of Health
Psychopharmacological agents and suicide risk reduction: ketamine and other approaches
RK Al Jurdi, A Swann, SJ Mathew
Current psychiatry reports 17, 1-10, 2015
Requisits: US National Institutes of Health
Impulsivity and suicidal behavior
AC Swann, M Lijffijt, B O’Brien, SJ Mathew
Recent advances in research on impulsivity and impulsive behaviors, 179-195, 2020
Requisits: US Department of Veterans Affairs
A pilot study of the effects of chronic paroxetine administration on hippocampal N-acetylaspartate in generalized anxiety disorder
SJ Mathew, RB Price, DC Shungu, X Mao, ELP Smith, JM Amiel, ...
Journal of Psychopharmacology 24 (8), 1175-1181, 2010
Requisits: US National Institutes of Health
Intravenous Ketamine for Treatment-Resistant Major Depressive Disorder.
M Aan het Rot, DS Charney, SJ Mathew
Primary Psychiatry 15 (4), 2008
Requisits: US National Institutes of Health
The tryptophan depletion challenge test in medical research: unresolved issues and broader implications for the use of physiological challenges to investigate and categorize …
PL Delgado
Biological psychiatry 69 (8), 718-719, 2011
Requisits: US National Institutes of Health
Choosing Between Ketamine and Electroconvulsive Therapy for Outpatients With Treatment-Resistant Depression—Advantage Ketamine?
SJ Mathew, MK Jha, A Anand
JAMA psychiatry 80 (12), 1187-1188, 2023
Requisits: US National Institutes of Health
Effect of concomitant benzodiazepines on the antidepressant effects of ketamine: findings from the RAPID intravenous ketamine study
A Feeney, BB Hoeppner, MP Freeman, M Flynn, DV Iosifescu, MH Trivedi, ...
The Journal of Clinical Psychiatry 84 (1), 43883, 2022
Requisits: US National Institutes of Health
Psychotherapy for mixed depression and mixed mania
B O’Brien, D Lee, AC Swann, SJ Mathew, M Lijffijt
Psychiatric Clinics 43 (1), 199-211, 2020
Requisits: US Department of Veterans Affairs
Anti-suicidal effects of IV ketamine in a real-world setting
B O'Brien, J Lee, S Kim, GS Nandra, P Pannu, A Tamman, D Amarneh, ...
Psychiatry research 331, 115604, 2024
Requisits: US National Institutes of Health
Heightened early-attentional stimulus orienting and impulsive action in men with antisocial personality disorder
M Lijffijt, SD Lane, SJ Mathew, MS Stanford, AC Swann
European archives of psychiatry and clinical neuroscience 267, 697-707, 2017
Requisits: US National Institutes of Health
In treatment-resistant major depression, ketamine was noninferior to ECT for treatment response
T Holsinger, P Riordan
Annals of Internal Medicine 176 (9), JC105, 2023
Requisits: Patient-Centered Outcomes Research Institute
Journal of Psychopathology and Clinical Science
S Hossein, ML Woody, B Panny, C Spotts, ML Wallace, SJ Mathew, ...
Requisits: US National Institutes of Health
Effect of Concomitant Benzodiazepines on the Antidepressant Effects of Ketamine
DV Iosifescu, MH Trivedi, G Sanacora, SJ Mathew, C DeBattista, ...
J Clin Psychiatry 84 (1), 22m14491, 2023
Requisits: US National Institutes of Health
Ketamine’s Rapid Antidepressant Action is Associated With Changes in the Functional Connectivity of the Habenula
AM Rivas-Grajales, R Salas, M Robinson, J Murrough, S Mathew
Biological Psychiatry 89 (9), S359-S360, 2021
Requisits: US National Institutes of Health
116. Results of the NIMH FAST-MAS Phase IIa Proof of Mechanism Study of the Effects of the Selective κ Opioid Antagonist JNJ-67953964 on fMRI Ventral Striatal Activity in …
A Krystal, D Pizzagalli, M Smoski, S Mathew, J Nurnberger, S Lisanby, ...
Biological Psychiatry 85 (10), S48-S49, 2019
Requisits: US National Institutes of Health
130. Childhood Trauma and Impulsivity in Adult Mood and Anxiety Disorders: Evidence of Behavioral Sensitization?
M Lijffijt, K Knott, T Iqbal, L Hirsch, K Floyd, S Iqbal, K Van Noy, H Wetzel, ...
Biological Psychiatry 81 (10), S54-S55, 2017
Requisits: US National Institutes of Health
Disponibles en algun lloc: 118
Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial
JW Murrough, DV Iosifescu, LC Chang, RK Al Jurdi, CE Green, AM Perez, ...
American Journal of Psychiatry 170 (10), 1134-1142, 2013
Requisits: US National Institutes of Health
Les dades de publicació i de finançament es determinen automàticament per mitjà d'un programa informàtic